Epiroc AB Series B (0YSV)
London Exchange · UK · prices in SEK · close of 19 Oct 2026
Key indicators
| Last close | SEK 218.60 |
|---|---|
| 52-week range | 164.87 – 238.92 |
| Return, 1 month / 3 months | +3.1% / +11.4% |
| Return, 1 year / 3 years | +17.8% / +33.4% |
| Trend | Uptrend |
| RSI (14) | 49 |
| Volatility (1 year) | 30.5% |
| Worst drawdown (1 year) | -18.2% |
| Average daily value traded | 19.90M SEK |
| Dividend yield | 1.7% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Epiroc AB is a Swedish industrial company that supplies equipment and services for mining and rock excavation. Its products include drill rigs, rock drilling tools, loaders and trucks used in underground and surface mining, along with hydraulic attachments and construction equipment. Customers are mainly mining companies, construction contractors and infrastructure projects, supported by a broad aftermarket business in spare parts, service and training. The company is based in Sweden and operates internationally.
The shares are listed on the London Exchange in UK under the code 0YSV, and the price on this page is in Swedish kronor (SEK). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Epiroc AB Series B (0YSV) trades on the London Exchange in UK. It last closed at SEK 218.60 on 19 October 2026.
Its price-based Market X-Ray is 67 out of 100 (a fair price profile), ranking 730 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 17.8% and over the last three months it rose 11.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 59 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 1.5% | ||
| From 52-week high | -8.2% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 11.4% | ||
| 6-month return | 2.6% | ||
| 12-month return, skipping the last month | 14.2% | ||
| Stability (higher is calmer) | 69 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -18.2% | ||
| Liquidity | 79 · Strong | Trades actively. | |
| Average daily value traded | 19.90M SEK | ||
| Zero-volume days | 0.0% | ||
| Income | 71 · Strong | Dividend is high and has been paid regularly. | |
| Dividend yield | 1.7% | ||
| Years with dividends | 6 |
Strengths
- Liquidity: Trades actively.
- Income: Dividend is high and has been paid regularly.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.9% |
|---|---|
| 1 month | +3.1% |
| 3 months | +11.4% |
| 6 months | +2.6% |
| 1 year | +17.8% |
| 3 years | +33.4% |
| 5 years | – |
Signals
| 50-day / 200-day average | 218.28 / 215.44 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 5.53 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 16 Oct 2026 | SEK 1.9000 |
| 6 May 2026 | SEK 1.9000 |
| 13 Oct 2025 | SEK 1.9000 |
| 9 May 2025 | SEK 1.9000 |
| 21 Oct 2024 | SEK 1.9000 |
| 15 May 2024 | SEK 1.9000 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.